Production (Stage)
MAIA Biotechnology, Inc.
MAIA
$1.80
-$0.15-7.69%
AMEX
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 9.45% | 33.80% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.41% | 19.48% | |||
| Operating Income | -8.41% | -19.48% | |||
| Income Before Tax | -26.47% | -30.55% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -26.47% | -30.55% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -26.47% | -30.55% | |||
| EBIT | -8.41% | -19.48% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -14.38% | -24.54% | |||
| Normalized Basic EPS | -14.24% | -24.58% | |||
| EPS Diluted | -14.38% | -24.54% | |||
| Normalized Diluted EPS | -14.24% | -24.58% | |||
| Average Basic Shares Outstanding | 10.61% | 4.80% | |||
| Average Diluted Shares Outstanding | 10.61% | 4.80% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||